| Pharmaceutical active ingredients: |
| HydrochlorothiazideLosartan Potassium |
| Available forms, composition and doses of Loplac-D: |
| N / A |
| Loplac-D medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA01 - Losartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Casasco Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lara-H | Hydrochlorothiazide; Losartan Potassium | Alkem Laboratories |
| Lartan-H | Hydrochlorothiazide; Losartan Potassium | Avinash Health Products |
| Loar-H | Hydrochlorothiazide; Losartan Potassium | Baroda Pharmaceutical |
| LO-H | Hydrochlorothiazide; Losartan Potassium | East West Pharma |
| Loortan Plus | Hydrochlorothiazide; Losartan Potassium | Therabel Pharma |
| Loril-HT | Hydrochlorothiazide; Losartan Potassium | Essweil Pharma |
| Lorista H | Hydrochlorothiazide; Losartan Potassium | KRKA |
| Lorista HD | Hydrochlorothiazide; Losartan Potassium | KRKA |
| Lorsar + HCT | Hydrochlorothiazide; Losartan Potassium | Hexal |
| Lortaan Plus | Hydrochlorothiazide; Losartan Potassium | Merck; Medinfar Laboratorio |